EstechPharma to export rebamipide to Japan

Published: 2009-02-16 06:57:00

Updated: 2009-02-16 06:57:00

EstechPharma said on February 12 that it will export rebamipide worth $840,000 to Japan until next month, since its first shipment.

Rebamipide is a novel compound synthesized by Otsuka Pharmaceutical Co., Ltd.

The company is expect to ship a total of rebamipide worth US$6 million within thi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK